Schizophrenia Drugs Market Size, Share & Trends Analysis Report By Type (Paranoid Schizophrenia, Hebephrenic Schizophrenia, Catatonic Schizophrenia, Undifferentiated Schizophrenia), By Therapeutic Class (Second Generation, Third Generation, Other), By Route of Administration (Injectable, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR4856DR | Pages: 156

Market Segmentation

  1. Schizophrenia Drugs Market, By Type  2022-2034 (USD MILLION/ Units)
    1. Paranoid Schizophrenia
    2. Hebephrenic Schizophrenia
    3. Catatonic Schizophrenia
    4. Undifferentiated Schizophrenia
  2. Schizophrenia Drugs Market, By Therapeutic Class  2022-2034 (USD MILLION/ Units)
    1. Second Generation
    2. Third Generation
    3. Other
  3. Schizophrenia Drugs Market, By Route of Administration  2022-2034 (USD MILLION/ Units)
    1. Injectable
    2. Oral
  4. Schizophrenia Drugs Market, By Distribution Channel  2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  5. Regional Schizophrenia Drugs Market
    1. North America
      1. North America Schizophrenia Drugs Market By Type  2022-2034 (USD MILLION/ Units)
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
      2. North America Schizophrenia Drugs Market By Therapeutic Class  2022-2034 (USD MILLION/ Units)
        1. Second Generation
        2. Third Generation
        3. Other
      3. North America Schizophrenia Drugs Market By Route of Administration  2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
      4. North America Schizophrenia Drugs Market By Distribution Channel  2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. U.S.
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Canada
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    2. Europe
      1. Europe Schizophrenia Drugs Market By Type  2022-2034 (USD MILLION/ Units)
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
      2. Europe Schizophrenia Drugs Market By Therapeutic Class  2022-2034 (USD MILLION/ Units)
        1. Second Generation
        2. Third Generation
        3. Other
      3. Europe Schizophrenia Drugs Market By Route of Administration  2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
      4. Europe Schizophrenia Drugs Market By Distribution Channel  2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. U.K.
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Germany
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. France
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. Spain
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Italy
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. Russia
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      11. Nordic
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      12. Benelux
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      13. Rest of Europe
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    3. APAC
      1. APAC Schizophrenia Drugs Market By Type  2022-2034 (USD MILLION/ Units)
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
      2. APAC Schizophrenia Drugs Market By Therapeutic Class  2022-2034 (USD MILLION/ Units)
        1. Second Generation
        2. Third Generation
        3. Other
      3. APAC Schizophrenia Drugs Market By Route of Administration  2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
      4. APAC Schizophrenia Drugs Market By Distribution Channel  2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. China
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Korea
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. Japan
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. India
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Australia
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. Singapore
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      11. Taiwan
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      12. South East Asia
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      13. Rest of Asia-Pacific
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Schizophrenia Drugs Market By Type  2022-2034 (USD MILLION/ Units)
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
      2. Middle East and Africa Schizophrenia Drugs Market By Therapeutic Class  2022-2034 (USD MILLION/ Units)
        1. Second Generation
        2. Third Generation
        3. Other
      3. Middle East and Africa Schizophrenia Drugs Market By Route of Administration  2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
      4. Middle East and Africa Schizophrenia Drugs Market By Distribution Channel  2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. UAE
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Turkey
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. Saudi Arabia
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. South Africa
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Egypt
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. Nigeria
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      11. Rest of MEA
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    5. LATAM
      1. LATAM Schizophrenia Drugs Market By Type  2022-2034 (USD MILLION/ Units)
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
      2. LATAM Schizophrenia Drugs Market By Therapeutic Class  2022-2034 (USD MILLION/ Units)
        1. Second Generation
        2. Third Generation
        3. Other
      3. LATAM Schizophrenia Drugs Market By Route of Administration  2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
      4. LATAM Schizophrenia Drugs Market By Distribution Channel  2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      5. Brazil
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Mexico
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. Argentina
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. Chile
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Colombia
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. Rest of LATAM
        1. Paranoid Schizophrenia
        2. Hebephrenic Schizophrenia
        3. Catatonic Schizophrenia
        4. Undifferentiated Schizophrenia
        5. Second Generation
        6. Third Generation
        7. Other
        8. Injectable
        9. Oral
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: